Meropenem Trihydrate: Broad-Spectrum Carbapenem Antibiotic for Advanced Antibacterial Research

Executive Summary: Meropenem trihydrate (SKU B1217, APExBIO) is a water-soluble, broad-spectrum carbapenem β-lactam antibiotic with demonstrated low MIC₉₀ values against a range of gram-negative and gram-positive pathogens, including Escherichia coli and Klebsiella pneumoniae (product page). Its primary mechanism is inhibition of bacterial cell wall synthesis via penicillin-binding proteins, resulting in cell lysis. Efficacy is pH-dependent, with enhanced activity at pH 7.5. Meropenem trihydrate remains effective in in vivo models such as acute necrotizing pancreatitis, where it reduces infection and tissue necrosis. The compound is a critical tool for resistance studies, as shown by recent LC-MS/MS metabolomics research that identifies key resistance phenotypes in carbapenemase-producing Enterobacterales (Dixon et al., 2025).

Biological Rationale

Carbapenem antibiotics, including Meropenem trihydrate, are often considered last-resort agents for multidrug-resistant bacterial infections (Dixon et al., 2025). Their broad-spectrum activity encompasses both gram-negative and gram-positive bacteria, as well as anaerobes. Meropenem trihydrate is especially valuable in experimental research for profiling resistance mechanisms and benchmarking antibacterial activity. Its β-lactam structure confers stability against many β-lactamases, making it suitable for studies involving extended spectrum β-lactamase (ESBL)- and carbapenemase-producing organisms. The compound is intended exclusively for scientific research use, not for diagnostic or medical application (APExBIO).

Mechanism of Action of Meropenem trihydrate

Meropenem trihydrate acts by binding to penicillin-binding proteins (PBPs), key enzymes in bacterial cell wall biosynthesis (Related Article). This binding inhibits peptidoglycan cross-linking, leading to weakened cell walls, cell lysis, and bacterial death. The compound exhibits superior stability against most β-lactamases, including ESBLs, due to its carbapenem core. Its activity is optimal at physiological pH (7.5), with decreased efficacy at acidic pH (5.5), a property important for experimental planning (APExBIO). Meropenem trihydrate's water solubility (≥20.7 mg/mL with gentle warming) facilitates high-concentration stock preparation. The compound is insoluble in ethanol but dissolves readily in DMSO (≥49.2 mg/mL).

Evidence & Benchmarks

• Meropenem trihydrate demonstrates low MIC₉₀ values against E. coli, K. pneumoniae, Enterobacter spp., Citrobacter spp., and Proteus mirabilis under standardized conditions (APExBIO datasheet, link).
• In acute necrotizing pancreatitis rat models, Meropenem trihydrate reduces hemorrhage, fat necrosis, and pancreatic infection, with enhanced effect when combined with deferoxamine (APExBIO, link).
• Recent LC-MS/MS metabolomics profiling distinguishes carbapenemase-producing Enterobacterales (CPE) from non-CPE in under 7 h using 21 metabolite biomarkers with high AUROC values (≥0.845) (Dixon et al., 2025).
• CPE resistance is primarily driven by carbapenemase enzyme production, efflux pumps, and porin mutations (Dixon et al., 2025).
• Meropenem trihydrate is stable at -20°C as a solid; aqueous solutions are for short-term use only (APExBIO).

This article updates and extends the protocol-driven focus of "Meropenem trihydrate (SKU B1217): Scenario-Driven Solutions" by integrating the latest LC-MS/MS metabolomics benchmarks and resistance biomarkers.

Applications, Limits & Misconceptions

Meropenem trihydrate is used in:

• Cell viability and cytotoxicity assays involving gram-negative and gram-positive bacteria.
• Resistance profiling and benchmarking in translational and preclinical workflows (see comparison: this article adds mechanistic clarity to prior translational research summaries).
• In vivo infection models such as acute pancreatitis.
• Metabolomics-driven studies to decipher resistance phenotypes (see contrast: this piece provides more granular benchmarks and resistance mechanism details).

Common Pitfalls or Misconceptions

• Not effective against all carbapenem-resistant organisms: Meropenem trihydrate is hydrolyzed by certain carbapenemases (e.g., KPC, NDM, OXA-48-like), limiting its efficacy in some CPE isolates (Dixon et al., 2025).
• Inappropriate for clinical use: The compound is intended for research purposes only and is not suitable for diagnostic or therapeutic applications (APExBIO).
• Stability limitations: Aqueous solutions degrade rapidly and must be used within a short timeframe; improper storage leads to loss of activity.
• pH sensitivity: Antibacterial activity decreases significantly at acidic pH (5.5); ensure physiological pH in assays.
• Not a universal β-lactamase inhibitor: While stable against many ESBLs, some β-lactamases can confer resistance.

Workflow Integration & Parameters

For optimal performance, dissolve Meropenem trihydrate in sterile water (≥20.7 mg/mL) with gentle warming, or in DMSO (≥49.2 mg/mL). Store the solid at -20°C. Prepare fresh solutions before each experiment for maximal potency. When designing resistance studies, incorporate controls for pH (use pH 7.5 buffers). Apply validated MIC testing protocols, referencing resistance definitions from the latest CLSI/EUCAST guidelines. For metabolomics studies, consider integrating LC-MS/MS profiling as described by Dixon et al., 2025 for rapid resistance detection. APExBIO provides comprehensive product datasheets and handling guidance (product page).

Conclusion & Outlook

Meropenem trihydrate (SKU B1217, APExBIO) provides a robust, well-characterized reagent for studying gram-negative and gram-positive bacterial infections, resistance mechanisms, and translational workflows. As carbapenem resistance rises globally, integrating Meropenem trihydrate into metabolomics and biomarker-driven assays will accelerate the development of rapid diagnostics and inform new therapeutic strategies (Dixon et al., 2025). For further protocol optimization and resistance scenario guidance, see this detailed workflow guide.